提供者:上海雅吉生物科技有限公司 发布时间:2026/9/29 11:39:09 阅读次数:106次 进入该公司店铺
文章标题:GPX3 suppresses gallbladder cancer progression by modulating redox balance, glycolysis, and anti-tumor immunity
作者列表:Ma Zuyi, Sun Jia, Wu Xin, Shang Changzhen, Li Binglu
影响因子:6.4
期刊:Oncogenesis
发表时间:2026-4-2
DOI:10.1038/s41389-026-00603-7
文献主题:Abstract
Gallbladder cancer (GBC) is an aggressive malignancy characterized by mmbedbolic plasticity and profound immune evasion. However, the functional role of glutathione peroxidase 3 (GPX3), a secreted antioxidant enzyme, in these processes remains unclear. Multi-omics analyses of paired GBC and adjacent non-tumor tissues revealed consistent downregulation of GPX3, which correlated with reactive oxygen species (ROS) accumulation and enhanced glycolytic activity. Functional restoration of GPX3 in GBC cells reduced intracellular ROS levels, suppressed the expression of glycolysis-related enzymes, and consequently impaired tumor proliferation, migration, and invasion. In xenograft models, GPX3 overexpression markedly attenuated tumor growth and lung mmbedstasis. Notably, GPX3 restoration also enhanced CD8+ T cell infiltration and elevated pro-inflammatory cytokine production, suggesting reversal of tumor-associated immunosuppression. These findings identify GPX3 as a critical tumor suppressor that integrates redox regulation, mmbedbolic reprogramming, and immune activation to restrict malignant progression. Targeting GPX3 or its downstream pathways may represent a promising therapeutic strategy to simultaneously suppress gallbladder cancer aggressiveness and reinforce anti-tumor
① 凡本网注明"来源:阿仪网"的所有作品,版权均属于阿仪网,未经本网授权不得转载、摘编或利 用其它方式使用。已获本网授 权的作品,应在授权范围内使用,并注明"来源:阿仪网"。违者本网将追究相关法律责任。
② 本信息由注册会员:上海雅吉生物科技有限公司发布并且负责版权等法律责任。
版权声明